Internal Linking: How To Get It Right for Your Audience and for SEO At its heart, a catalyst saves energy. That’s what internal linking does for your content promotion and distribution. The only problem? Most content...
Capivasertib Plus Fulvestrant Gets Priority Review for HR-Positive Advanced Breast Cancer The Food and Drug Administration (FDA) has accepted for Priority Review the New Drug Application (NDA) for capivasertib in...
Monthly Prescribing Reference (MPR): Drugs in the Pipeline
Als mensen voor het schap nadenken, ben je verloren ‘Rebranden is niet gemakkelijk; vernieuwen is namelijk belangrijk, maar dat moet je ook niet overdrijven als marketeer’, aldus Revet. ...
Leiden University Medical Center and Intravacc to start clinical trial with new intranasal corona vaccine Intravacc, a global leader in translational research and development of therapeutic vaccines and vaccines against...
Five things for pharma marketers to know: InCarda Therapeutics stopped its Phase 3 trial for its arrhythmia drug FlecIH-103 due to “limited efficacy upon blinded review.” Telehealth company Ro halted advertising of Novo...
COVID-19 Vaccines FRIDAY, Oct. 23, 2020 — At a meeting of the U.S. Food and Drug Administration vaccine advisory board, some experts warned that the guidelines requiring two months of safety data after a volunteer...
US FDA accepts for review sBLA for Merck’s Keytruda in combo with chemotherapy to treat advanced or unresectable biliary tract cancer Merck, known as MSD outside of the United States and Canada, announced the US...
Integrale zorg als kans voor de farmaceutische industrie Redacteur Marloes Meddens-Bakker, in het dagelijks leven advocaat bij MOON legal & compliance, ging in gesprek met neuroloog-in-opleiding Wardell Amerika en...
Five things for pharma marketers to know: Food and Drug Administration advisers plan to request additional studies for the Vertex Pharmaceuticals/CRISPR Therapeutics sickle cell disease gene therapy exa-cel. Pharmacy...
We gebruiken cookies om ervoor te zorgen dat onze website zo soepel mogelijk draait. Als u doorgaat met het gebruiken van de website, gaan we er vanuit dat u ermee instemt.